Skip to main content

Main menu

  • Home
  • Current issue
  • ERJ Early View
  • Past issues
  • ERS Guidelines
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • Open access
    • COVID-19 submission information
    • Peer reviewer login
  • Alerts
  • Subscriptions
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

User menu

  • Log in
  • Subscribe
  • Contact Us
  • My Cart

Search

  • Advanced search
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

Login

European Respiratory Society

Advanced Search

  • Home
  • Current issue
  • ERJ Early View
  • Past issues
  • ERS Guidelines
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • Open access
    • COVID-19 submission information
    • Peer reviewer login
  • Alerts
  • Subscriptions

Applicability of dry powder inhalers in children with CF

Anne Lexmond, Paul Hagedoorn, Erik Frijlink, Bart Rottier, Anne De Boer
European Respiratory Journal 2016 48: PA4857; DOI: 10.1183/13993003.congress-2016.PA4857
Anne Lexmond
1Pharmaceutical Technology and Biopharmacy, University of Groningen, Groningen, Netherlands
2Institute of Pharmaceutical Science, King's College London, London, United Kingdom
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Paul Hagedoorn
1Pharmaceutical Technology and Biopharmacy, University of Groningen, Groningen, Netherlands
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Erik Frijlink
1Pharmaceutical Technology and Biopharmacy, University of Groningen, Groningen, Netherlands
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Bart Rottier
3Pediatric Pulmonology and Pediatric Allergology, University Medical Center Groningen, Groningen, Netherlands
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Anne De Boer
1Pharmaceutical Technology and Biopharmacy, University of Groningen, Groningen, Netherlands
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
Loading

Abstract

Introduction Many children with CF are treated with inhaled antibiotics, mostly by nebulisation, although first generation capsule-based dry powder inhalers (DPIs) with antibiotics are now available. Such inhalers generally require inhaled volumes ≥1 L and high flow rates (≥60 L/min) to deliver the entire dose.

Aim To determine whether children with CF are able to perform the inspiratory manoeuvres needed to operate a capsule-based DPI effectively and how their inhalations are affected by the inhaler resistance and their disease.

Methods We recorded inspiratory flow manoeuvres of children with and without CF (n=35 and n=103 respectively, 4-14 years old) through a test inhaler with variable airflow resistance and calculated total inhaled volume (V) and peak inspiratory flow rate (PIF).

Results Minimal V (0.5 L) and PIF values (20 L/min) of children with CF and healthy controls were the same, but the age-related increases of both parameters were slightly higher for the healthy controls (p<0.01 and p=0.08 respectively; see Figure). Resistance in the range 0.31-0.45 kPa0.5.L.min-1 (medium to high) affected PIF but not total inhaled volume.

Figure
  • Download figure
  • Open in new tab
  • Download powerpoint

Conclusions Our findings indicate that inhaled volumes and PIFs of the youngest children (with and without CF) are too low to operate currently marketed antibiotic DPIs effectively. By implication, the development of DPIs specifically for children is highly desired.

  • Treatments
  • Infections
  • Copyright ©the authors 2016
Previous
Back to top
Vol 48 Issue suppl 60 Table of Contents
  • Table of Contents
  • Index by author
Email

Thank you for your interest in spreading the word on European Respiratory Society .

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Applicability of dry powder inhalers in children with CF
(Your Name) has sent you a message from European Respiratory Society
(Your Name) thought you would like to see the European Respiratory Society web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Applicability of dry powder inhalers in children with CF
Anne Lexmond, Paul Hagedoorn, Erik Frijlink, Bart Rottier, Anne De Boer
European Respiratory Journal Sep 2016, 48 (suppl 60) PA4857; DOI: 10.1183/13993003.congress-2016.PA4857

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
Applicability of dry powder inhalers in children with CF
Anne Lexmond, Paul Hagedoorn, Erik Frijlink, Bart Rottier, Anne De Boer
European Respiratory Journal Sep 2016, 48 (suppl 60) PA4857; DOI: 10.1183/13993003.congress-2016.PA4857
Reddit logo Technorati logo Twitter logo Connotea logo Facebook logo Mendeley logo

Jump To

  • Article
  • Figures & Data
  • Info & Metrics
  • Tweet Widget
  • Facebook Like
  • Google Plus One

More in this TOC Section

  • Efficacy and safety of inhaled antibiotics for chronic pseudomonas infection in cystic fibrosis: Network meta-analysis
  • Human neutrophils release bioactive inflammasome complexes; relevance for cystic fibrosis
  • Infant lung function testing: First in vivo report of a novel inert gas washout method to measure LCI
Show more 7.3 Cystic Fibrosis

Related Articles

Navigate

  • Home
  • Current issue
  • Archive

About the ERJ

  • Journal information
  • Editorial board
  • Press
  • Permissions and reprints
  • Advertising

The European Respiratory Society

  • Society home
  • myERS
  • Privacy policy
  • Accessibility

ERS publications

  • European Respiratory Journal
  • ERJ Open Research
  • European Respiratory Review
  • Breathe
  • ERS books online
  • ERS Bookshop

Help

  • Feedback

For authors

  • Instructions for authors
  • Publication ethics and malpractice
  • Submit a manuscript

For readers

  • Alerts
  • Subjects
  • Podcasts
  • RSS

Subscriptions

  • Accessing the ERS publications

Contact us

European Respiratory Society
442 Glossop Road
Sheffield S10 2PX
United Kingdom
Tel: +44 114 2672860
Email: journals@ersnet.org

ISSN

Print ISSN:  0903-1936
Online ISSN: 1399-3003

Copyright © 2023 by the European Respiratory Society